Cargando…
Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients
PURPOSE: This randomized phase II study was conducted to investigate the efficacy of cryotherapy in preventing peripheral neuropathy and dermatological adverse events in breast cancer patients treated with weekly paclitaxel. METHODS: Patients treated with 12 weekly doses of paclitaxel for breast can...
Autores principales: | Shigematsu, Hideo, Hirata, Taizo, Nishina, Mai, Yasui, Daisuke, Ozaki, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447649/ https://www.ncbi.nlm.nih.gov/pubmed/32036471 http://dx.doi.org/10.1007/s00520-020-05345-9 |
Ejemplares similares
-
A case report of locally advanced triple negative breast cancer showing pathological complete response to weekly paclitaxel with bevacizumab treatment following disease progression during anthracycline-based neoadjuvant chemotherapy
por: Shigematsu, Hideo, et al.
Publicado: (2017) -
Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1–2 and cN0 breast cancer
por: Shigematsu, Hideo, et al.
Publicado: (2019) -
Persistent weekly paclitaxel-induced peripheral neuropathy in early breast cancer patients enrolled in a randomized trial of cryotherapy
por: Shigematsu, Hideo, et al.
Publicado: (2023) -
Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer
por: Shigematsu, Hideo, et al.
Publicado: (2018) -
The Safety and Efficacy of Cryotherapy in the Prevention of Paclitaxel-Induced Neuropathy: A Systematic Review
por: Hossain, Md Fahad, et al.
Publicado: (2023)